A phase 3 rheumatoid arthritis trial of Lynk Pharmaceuticals’ JAK1 inhibitor in China has hit its primary endpoint, boosting ...

Both upadacitinib (Rinvoq) and adalimumab (Humira) are proven effective in rheumatoid arthritis (RA) and psoriatic arthritis ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

SetPoint Medical, a company dedicated to developing therapies for people living with chronic autoimmune diseases, today ...

Al-Gahtani, S. (2026) Review of Literature Investigating the Correlation between Prevalence of Risk Factors Associated with Both Rheumatoid Arthritis and Cardiovascular Diseases. Open Journal of ...

It can be a real pain in the neck. Rheumatoid arthritis, or RA, is an autoimmune disease in which the body mistakenly attacks the lining of the joints, causing painful swelling and stiffness. About ...

People with rheumatoid arthritis (RA) may experience hair loss or thinning, though it’s not usually caused by the disease but by medications used to treat RA. Sometimes people with RA have other ...

Weaker immune response against COVID-19 may be attributed to the more targeted immunosuppressive mechanism of biologic DMARDs. Rheumatoid arthritis (RA) patients receiving biologic disease-modifying ...

Weaker immune response against COVID-19 may be attributed to the more targeted immunosuppressive mechanism of biologic DMARDs. Rheumatoid arthritis (RA) patients receiving biologic disease-modifying ...

Nonadherence to DMARDs in RA varies widely, with rates from 1.5% to 100% across different studies and DMARD classes. The review identified 31 unique nonadherence measures, with indirect methods like ...

For the 5 tests, the cumulative probabilities of very abnormal laboratory results varied from 0.2% for leukocyte count to 6.6% for eGFR at 2 years and from 0.3 to 11%, respectively, at 5 years.